FDA Approves Wearable Infusion Device for Advanced Parkinson Disease

THURSDAY, Feb. 6, 2025-- The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with...